![a row of open test tubes with the first one labeled COVID-19](https://www.uc.edu/news/articles/2020/06/n20923581/jcr:content/image.img.cq5dam.thumbnail.500.500.jpg/1592399382848.jpg)
UC, UC Health to launch Phase 3 clinical trial for COVID-19 vaccine
Vaccine uses a genetic code to produce proteins that may generate protective antibodies
Researchers at the University of Cincinnati and UC Health will host a Phase 3 clinical trial to evaluate the effectiveness of a vaccine for COVID-19, the respiratory illness caused by the novel coronavirus SARS-CoV-2.
UC is one of approximately 90 sites across the United States selected for the study, which will administer the vaccine candidate mRNA-1273 to volunteer participants and monitor its efficacy in eliciting an immune response that provides protection from COVID-19. The National Institute of Allergy and Infectious Diseases, (NIAID), part of the National Institutes of Health, is funding the study.
Carl Fichtenbaum, MD, of the UC College of Medicine Division of Infectious Diseases, medical director of the COVID-19 vaccine trial. Photo/Colleen Kelley/UC Creative + Brand
“UC was chosen because we have a proven track record of high-quality research and are the number one site in the NIAID-funded, AIDS Clinical Trials Group in the U.S. We are proud to bring leading-edge research to Cincinnati so that we can help our community battle the COVID-19 pandemic and be part of the solution,” said Carl Fichtenbaum, MD, professor in the Division of Infectious Diseases at the UC College of Medicine and a UC Health physician.
Fichtenbaum is co-investigator of the study and will serve as medical director.
Read the full story here.
Featured photo of COVID-19 vials by Colleen Kelley/UC Creative + Brand
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
UC global health expert hones leadership skills as Fulbright...
July 26, 2024
The University of Cincinnati’s Michelle Burbage worked as a Fulbright Specialist in Tbilisi, Georgia, leading workshops and hands-on activities to build public global health research programs.
Health effects of secondhand marijuana smoke
![Local 12 logo](/content/dam/refresh/uc-news/news-icons/dark/wkrc-logo-dark.png)
July 24, 2024
Local 12 featured the University of Cincinnati's LaTrice Montgomery in a story on the relatively unknown effects of secondhand marijuana smoke.
Urgent need for blood donors during summer months
July 23, 2024
Hoxworth Blood Center, University of Cincinnati, is calling on the Tri-State community to make a lifesaving blood or platelet donation to help local patients in need during the critical summer months.